Parkman Healthcare Partners’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$50.9M Buy
154,771
+49,299
+47% +$17.7M 5.24% 1
2025
Q4
$37.1M Buy
105,472
+41,364
+65% +$15.1M 3.53% 4
2025
Q3
$23.7M Buy
64,108
+13,732
+27% +$5.31M 2.47% 9
2025
Q2
$19.9M Sell
50,376
-27,314
-35% -$10.2M 2.29% 12
2025
Q1
$28.9M Sell
77,690
-27
-0% -$10.3K 3.43% 4
2024
Q4
$28M Buy
77,717
+49,717
+178% +$18.4M 3.73% 5
2024
Q3
$10.1M Buy
+28,000
New +$9.66M 1.29% 25

Other funds holding SYK

Parkman Healthcare Partners's SYK Position: Q1 2026 in Review

Parkman Healthcare Partners increased its Stryker (SYK) stake by 47% in Q1 2026, buying an estimated $17.7M and bringing the position to 154,771 shares worth $50.9M. The position accounts for 5.24% of the portfolio, ranked #1.

Parkman Healthcare Partners first reported a position in SYK in Q3 2024 and has held it in 7 quarters since. 2,295 funds tracked by Wall St. Rank hold SYK as of Q1 2026.

  • Parkman Healthcare Partners held 154,771 shares of Stryker worth $50.9M as of Q1 2026.
  • Parkman Healthcare Partners bought 49,299 Stryker shares in Q1 2026, an estimated $17.7M.
  • Stryker made up 5.24% of Parkman Healthcare Partners's portfolio in Q1 2026, its #1 holding.
  • Parkman Healthcare Partners first reported a position in Stryker in Q3 2024 and has held it in 7 quarters since.
  • 2,295 funds tracked by Wall St. Rank held Stryker as of Q1 2026.

Based on Parkman Healthcare Partners's 13F filing for Q1 2026, filed 15 May 2026.